Although IGFBP6-mediated regulation of CCL2 is independent of IGF2, the potential involvement of IGF2-dependent pathways in IGFBP6’s modulation of sepsis progression remains an open question requiring systematic investigation. The gene discussed is IGF2; the disease is Sepsis.